Open AccessFrom hepatocytes to stem and progenitor cells for liver regenerative medicine: advances and clinical perspectives
Author(s) -
Sokal E. M.
Publication year - 2011
Publication title -
cell proliferation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.647
H-Index - 74
eISSN - 1365-2184
pISSN - 0960-7722
DOI - 10.1111/j.1365-2184.2010.00730.x
Subject(s) - progenitor cell , regenerative medicine , economic shortage , hepatocyte , stem cell , transplantation , liver disease , biology , cryopreservation , microbiology and biotechnology , bioinformatics , medicine , immunology , in vitro , embryo , linguistics , philosophy , biochemistry , government (linguistics)
The parenchymal liver cell is a unique fully functional metabolic unit that can be used for liver regenerative medicine to restore function of the diseased organ; the aim of the procedure is to prevent progression of end‐stage disease. The alternative, orthotopic liver transplantation, is highly intrusive, irreversible and limited by general organ shortage. Mature liver cell – hepatocyte – transplantation has been shown to have short‐ to medium‐term efficacy for correction of miscellaneous inborn errors of metabolism. However, although proof of concept has been established, the procedure has not yet achieved full success, due to limited durability of functional benefit. Hepatocyte procurement is also restricted by organ shortage, and their storage is difficult due to poor tolerance of cryopreservation. Alternative cell sources are therefore needed for development and wider accessibility of cell‐based liver regenerative medicine. Besides safety, the main challenge for these alternative cells is to acquire similar levels of functionality once implanted into the target organ. In this respect, liver derived progenitor cells may have some advantages over stem cells derived from other tissues.